Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.

NBSE

NeuBase Therapeutics (NBSE)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:NBSE
DataOraFonteTitoloSimboloCompagnia
03/07/202406:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:NBSENeuBase Therapeutics Inc
27/06/202423:25Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NASDAQ:NBSENeuBase Therapeutics Inc
27/06/202423:20Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:NBSENeuBase Therapeutics Inc
27/06/202422:48Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:NBSENeuBase Therapeutics Inc
27/06/202422:46Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NBSENeuBase Therapeutics Inc
03/06/202422:08Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:NBSENeuBase Therapeutics Inc
16/05/202416:07Edgar (US Regulatory)Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securitiesNASDAQ:NBSENeuBase Therapeutics Inc
05/04/202422:05GlobeNewswire Inc.NeuBase Therapeutics Announces Receipt of Notice from NasdaqNASDAQ:NBSENeuBase Therapeutics Inc
28/12/202312:15Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:NBSENeuBase Therapeutics Inc
27/11/202315:00GlobeNewswire Inc.Psychemedics Corporation Appoints Daniella Mehalik as VP - FinanceNASDAQ:NBSENeuBase Therapeutics Inc
09/11/202322:11Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NBSENeuBase Therapeutics Inc
21/09/202302:42Edgar (US Regulatory)Form 5 - Annual statement of changes in beneficial ownership of securitiesNASDAQ:NBSENeuBase Therapeutics Inc
20/09/202323:28Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:NBSENeuBase Therapeutics Inc
18/09/202322:32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NBSENeuBase Therapeutics Inc
12/09/202323:20Edgar (US Regulatory)Form 3/A - Initial statement of beneficial ownership of securities: [Amend]NASDAQ:NBSENeuBase Therapeutics Inc
08/09/202313:00GlobeNewswire Inc.NeuBase Therapeutics Issues Statement Regarding Filing By ShareholderNASDAQ:NBSENeuBase Therapeutics Inc
06/09/202316:00PR Newswire (US)SYMETRYX CORPORATION ACQUIRES 20% STOCK IN NEUBASENASDAQ:NBSENeuBase Therapeutics Inc
01/09/202320:51Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:NBSENeuBase Therapeutics Inc
31/08/202317:50Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNASDAQ:NBSENeuBase Therapeutics Inc
11/08/202312:20Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:NBSENeuBase Therapeutics Inc
11/08/202312:15Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:NBSENeuBase Therapeutics Inc
01/08/202322:45Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:NBSENeuBase Therapeutics Inc
28/07/202312:03Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:NBSENeuBase Therapeutics Inc
07/07/202322:11Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:NBSENeuBase Therapeutics Inc
30/06/202314:43Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:NBSENeuBase Therapeutics Inc
30/06/202314:42Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:NBSENeuBase Therapeutics Inc
30/06/202314:41Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:NBSENeuBase Therapeutics Inc
05/06/202322:06Edgar (US Regulatory)Quarterly Transition Report (10-qt)NASDAQ:NBSENeuBase Therapeutics Inc
22/05/202313:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NBSENeuBase Therapeutics Inc
11/05/202322:06Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:NBSENeuBase Therapeutics Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:NBSE
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network